114 related articles for article (PubMed ID: 9892524)
1. The effect of subinhibitory concentrations of antibiotics on adherence of Pseudomonas aeruginosa to cystic fibrosis (CF) and non-CF-affected tracheal epithelial cells.
Wolter JM; McCormack JG
J Infect; 1998 Nov; 37(3):217-23. PubMed ID: 9892524
[TBL] [Abstract][Full Text] [Related]
2. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
Millar BC; Rendall JC; Downey DG; Moore JE
J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
[TBL] [Abstract][Full Text] [Related]
3. RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells.
Van Ewijk BE; Wolfs TF; Aerts PC; Van Kessel KP; Fleer A; Kimpen JL; Van der Ent CK
Pediatr Res; 2007 Apr; 61(4):398-403. PubMed ID: 17515861
[TBL] [Abstract][Full Text] [Related]
4. Effects of antibiotics on adherence of Pseudomonas aeruginosa and Pseudomonas fluorescens to A549 pneumocyte cells.
Di Martino P; Rebière-Huët J; Hulen C
Chemotherapy; 2000; 46(2):129-34. PubMed ID: 10671764
[TBL] [Abstract][Full Text] [Related]
5. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
[TBL] [Abstract][Full Text] [Related]
6. Reduction in the adherence of Pseudomonas aeruginosa to native cystic fibrosis epithelium with anti-asialoGM1 antibody and neuraminidase inhibition.
Davies J; Dewar A; Bush A; Pitt T; Gruenert D; Geddes DM; Alton EW
Eur Respir J; 1999 Mar; 13(3):565-70. PubMed ID: 10232427
[TBL] [Abstract][Full Text] [Related]
7. Are antipseudomonal antibiotics really beneficial in acute respiratory exacerbations of cystic fibrosis?
Wolter JM; Bowler SD; McCormack JG
Aust N Z J Med; 1999 Feb; 29(1):15-21. PubMed ID: 10200808
[TBL] [Abstract][Full Text] [Related]
8. Protection of human respiratory epithelium from Pseudomonas aeruginosa adherence by phosphatidylglycerol liposomes.
Girod de Bentzmann S; Bajolet-Laudinat O; Dupuit F; Pierrot D; Fuchey C; Plotkowski MC; Puchelle E
Infect Immun; 1994 Feb; 62(2):704-8. PubMed ID: 8300228
[TBL] [Abstract][Full Text] [Related]
9. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
Banerjee D; Stableforth D
Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids can affect Pseudomonas aeruginosa (ATCC 27853) internalization and intracellular calcium concentration in cystic fibrosis bronchial epithelial cells.
Hussain R; Shahror R; Karpati F; Roomans GM
Exp Lung Res; 2015; 41(7):383-92. PubMed ID: 26151838
[TBL] [Abstract][Full Text] [Related]
11. Effect of subinhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to bronchial mucins collected from cystic fibrosis patients.
Carfartan G; Gerardin P; Turck D; Husson MO
J Antimicrob Chemother; 2004 Apr; 53(4):686-8. PubMed ID: 14998983
[No Abstract] [Full Text] [Related]
12. Effects of characterised Pseudomonas aeruginosa exopolysaccharides on adherence to human tracheal cells.
Marty N; Pasquier C; Dournes JL; Chemin K; Chavagnat F; Guinand M; Chabanon G; Pipy B; Montrozier H
J Med Microbiol; 1998 Feb; 47(2):129-34. PubMed ID: 9879955
[TBL] [Abstract][Full Text] [Related]
13. Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence.
Scheid P; Kempster L; Griesenbach U; Davies JC; Dewar A; Weber PP; Colledge WH; Evans MJ; Geddes DM; Alton EW
Eur Respir J; 2001 Jan; 17(1):27-35. PubMed ID: 11307750
[TBL] [Abstract][Full Text] [Related]
14. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa.
Wozniak DJ; Keyser R
Chest; 2004 Feb; 125(2 Suppl):62S-69S; quiz 69S. PubMed ID: 14872002
[TBL] [Abstract][Full Text] [Related]
15. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
Sousa AM; Monteiro R; Pereira MO
Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.
Millar BC; McCaughan J; Rendall JC; Downey DG; Moore JE
J Clin Pharm Ther; 2018 Feb; 43(1):92-100. PubMed ID: 29293275
[TBL] [Abstract][Full Text] [Related]
17. Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.
Greipel L; Fischer S; Klockgether J; Dorda M; Mielke S; Wiehlmann L; Cramer N; Tümmler B
Antimicrob Agents Chemother; 2016 Nov; 60(11):6726-6734. PubMed ID: 27572404
[TBL] [Abstract][Full Text] [Related]
18. Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations.
Wu YL; Scott EM; Po AL; Tariq VN
APMIS; 1999 Jun; 107(6):585-92. PubMed ID: 10379686
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ
J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442
[TBL] [Abstract][Full Text] [Related]
20. Glucosylceramide Critically Contributes to the Host Defense of Cystic Fibrosis Lungs.
Kovacic B; Sehl C; Wilker B; Kamler M; Gulbins E; Becker KA
Cell Physiol Biochem; 2017; 41(3):1208-1218. PubMed ID: 28427052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
